Yang, Xin http://orcid.org/0000-0001-6632-9608
Triboulet, Robinson
Liu, Qi
Sendinc, Erdem
Gregory, Richard I. http://orcid.org/0000-0001-8090-8673
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA232115, R01CA233671)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 16 August 2022
Accepted: 14 December 2022
First Online: 23 December 2022
Competing interests
: R.I.G. is a co-founder, scientific advisory board member, and equity holder of 28/7 Therapeutics and Theonys. All other authors declare no competing interests.